Ronald Wayne Takvorian, M.D.
Concepts are derived automatically from a person's publications.
The timeline below shows the dates (blue tick marks) of publications associated with Ronald Takvorian's top concepts. The average publication date for each concept is shown as a red circle, illustrating changes in the primary topics that Ronald Takvorian has written about over time.
Hodgkin DiseaseLymphoma, B-Cell, Marginal ZoneAntineoplastic Combined Chemotherapy ProtocolsLymphomaVinblastineVidarabineLymphoma, Large B-Cell, DiffuseLeukemia, Hairy CellPancytopeniaCyclophosphamideDacarbazineNeurotoxicity SyndromesAdeninePiperidinesLeukemia, Lymphocytic, Chronic, B-CellImmunotherapy, AdoptiveLymphoma, Mantle-Cell
To see the data from this visualization as text,
click here.
| Name | Number of Publications | First Publication Year | Most Recent Publication Year | Average Publication Date |
|---|
| Hodgkin Disease | 4 | 2001 | 2019 | May 2009 |
| Lymphoma, B-Cell, Marginal Zone | 3 | 2005 | 2015 | December 2009 |
| Antineoplastic Combined Chemotherapy Protocols | 9 | 1984 | 2023 | June 2012 |
| Lymphoma | 4 | 2005 | 2023 | July 2013 |
| Vinblastine | 2 | 2011 | 2019 | April 2015 |
| Vidarabine | 4 | 2009 | 2024 | January 2017 |
| Lymphoma, Large B-Cell, Diffuse | 2 | 2011 | 2023 | September 2017 |
| Leukemia, Hairy Cell | 1 | 2018 | 2018 | September 2018 |
| Pancytopenia | 1 | 2018 | 2018 | September 2018 |
| Cyclophosphamide | 3 | 2013 | 2024 | January 2019 |
| Dacarbazine | 1 | 2019 | 2019 | June 2019 |
| Neurotoxicity Syndromes | 2 | 2019 | 2023 | July 2021 |
| Adenine | 2 | 2019 | 2024 | October 2021 |
| Piperidines | 2 | 2019 | 2024 | October 2021 |
| Leukemia, Lymphocytic, Chronic, B-Cell | 4 | 2019 | 2024 | February 2022 |
| Immunotherapy, Adoptive | 3 | 2019 | 2023 | April 2022 |
| Lymphoma, Mantle-Cell | 1 | 2023 | 2023 | December 2023 |